Clinical Trial Update: A Study to Evaluate the Effect of Multiple Doses of JNJ-56021927 on the Pharmacokinetics of Multiple Cytochrome P450 and Transporter Substrates in Participants With Castration-Resistant Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the effect of multiple doses of JNJ-56021927 on the pharmacokinetics of various cytochrome P450 substrates and transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• JNJ-56021927

Snippet

Sponsor: Aragon Pharmaceuticals, Inc. | Conditions: Prostatic Neoplasms, Castration-Resistant | Phase 1 | Status: ACTIVE_NOT_RECRUITING